<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> ulcerative <z:hpo ids='HP_0010280'>stomatitis</z:hpo> protein (CUSP), the most abundant cutaneous isoform of p63, is a p53-related gene essential for epithelial development </plain></SENT>
<SENT sid="1" pm="."><plain>CUSP lacks the N-terminal transactivation domain found on other p53 family members and has been shown to inhibit p53 function in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, biopsies of <z:mpath ids='MPATH_458'>normal</z:mpath> skin (21 of 21), benign <z:hpo ids='HP_0002664'>neoplasms</z:hpo> [<z:mpath ids='MPATH_158'>seborrheic keratosis</z:mpath> (3 of 3), <z:e sem="disease" ids="C0037293" disease_type="Neoplastic Process" abbrv="">acrochordon</z:e> (2 of 3), and <z:e sem="disease" ids="C0043037" disease_type="Disease or Syndrome" abbrv="">verruca</z:e> plana (3 of 3)], and <z:hpo ids='HP_0002860'>squamous cell carcinomas</z:hpo> (<z:mp ids='MP_0004207'>SCC</z:mp>) (4 of 4) displayed strong nuclear CUSP immuno-reactivity in epidermal cells </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast few <z:hpo ids='HP_0002671'>basal cell carcinomas</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e>) (7 of 27) and sebaceous <z:e sem="disease" ids="C0027960" disease_type="Neoplastic Process" abbrv="">nevi</z:e> (1 of 2) displayed this pattern of CUSP immunoreactivity </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, biopsies of cutaneous conditions characterized by sonic hedgehog (SHH) pathway dysregulation were more than 86 times as likely to lack CUSP/p63 immunofluorescence as were other cutaneous samples </plain></SENT>
<SENT sid="5" pm="."><plain>Adjacent <z:mpath ids='MPATH_458'>normal</z:mpath>-appearing skin from patients with <z:hpo ids='HP_0002671'>basal cell nevus</z:hpo> syndrome (BCNS) (2 of 3) also lacked CUSP immuno-staining </plain></SENT>
<SENT sid="6" pm="."><plain>Lastly, a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> arising in a patched heterozygous mouse also lacked CUSP immuno-staining </plain></SENT>
<SENT sid="7" pm="."><plain>Because CUSP <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein were detected via Northern and Western analysis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCC</z:e> samples lacking CUSP immuno-staining, we sequenced the coding region of CUSP from two non-staining <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCCs</z:e> but found no mutations </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, CUSP appears to be present, unmutated, and yet frequently undetectable by immunofluorescence in cutaneous lesions in both humans and mice that are associated with SHH pathway dysregulation (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BCCs</z:e>, BCNS, and <z:hpo ids='HP_0010815'>nevus sebaceous</z:hpo>) </plain></SENT>
</text></document>